Pro-adrenomedullin and Community-Acquired Pneumonia
Author Information
Author(s): Christ-Crain Mirjam, Morgenthaler Nils G, Stolz Daiana, Müller Christian, Bingisser Roland, Harbarth Stephan, Tamm Michael, Struck Joachim, Bergmann Andreas, Müller Beat
Primary Institution: University Hospital Basel, Switzerland
Hypothesis
The study investigates the value of pro-adrenomedullin levels for severity assessment and outcome prediction in community-acquired pneumonia.
Conclusion
Pro-adrenomedullin is a useful tool for risk stratification in patients with community-acquired pneumonia.
Supporting Evidence
- Pro-adrenomedullin levels increased with the severity of pneumonia.
- Patients who died had higher pro-adrenomedullin levels on admission compared to survivors.
- Pro-adrenomedullin improved prognostic accuracy when combined with the pneumonia severity index.
Takeaway
Pro-adrenomedullin helps doctors understand how serious a patient's pneumonia is and how likely they are to get better.
Methodology
A prospective observational study measuring pro-adrenomedullin levels and other biomarkers in patients with community-acquired pneumonia.
Potential Biases
Potential overemphasis on age in the pneumonia severity index and inter-observer variability in clinical assessments.
Limitations
The study did not measure D-Dimer levels and cannot conclude about the usefulness of pro-adrenomedullin to predict the etiology of CAP.
Participant Demographics
Mean age of participants was 69.6 years, with 61.9% male and 24.2% current smokers.
Statistical Information
P-Value
p < 0.001
Confidence Interval
95% CI 0.71–0.81
Statistical Significance
p < 0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website